Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
The Journal of Headache and Pain|June 8, 2022
Real-World experience of interictal burden and treatment in migraine: a qualitative interview studySiu Hing Lo, Katy Gallop, Timothy Smith, et al.International Journal of Cancer|February 1, 2014
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinomaMei-Hsuan Lee, Hwai-I Yang, Sheng-Nan Lu, et al.Plos One|May 8, 2014
Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodiesMei-Hsuan Lee, Sheng-Nan Lu, Yong Yuan, et al.Cerebellum (London, England)|May 6, 2024
Development and Validation of SCACOMS, a Composite Scale for Assessing Disease Progression and Treatment Effects in Spinocerebellar AtaxiaGilbert L'Italien, Evan Popoff, Basia Rogula, et al.Kidney International|May 24, 2017
High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney diseaseTai-Shuan Lai, Mei-Hsuan Lee, Hwai-I Yang, et al.Hepatology (Baltimore, Md.)|April 4, 2017
Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV studyTai-Shuan Lai, Mei-Hsuan Lee, Hwai-I Yang, et al.Schizophrenia Research|November 1, 2008
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapineJohn W Newcomer, Jonathan M Meyer, Ross A Baker, et al.Cerebellum (London, England)|September 1, 2025
Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar AtaxiaMichele Potashman, Maggie Heinrich, Katja Rudell, et al.Scientific Reports|November 26, 2015
Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma RiskMei-Hsuan Lee, Hwai-I Yang, Sheng-Nan Lu, et al.Psychiatry Research|August 24, 2005
Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorderRajiv Tandon, Robert F Devellis, Jian Han, et al.Pageof 7